Viance

Viance is a specialized cell and gene therapy (CGT) company that operates as a contract development and manufacturing organization (CDMO) focused on accelerating the path to clinic for advanced therapies. The company provides a comprehensive suite of services, including process development, analytical development, and GMP manufacturing, specifically tailored for complex modalities like CAR-T and viral vectors. By leveraging proprietary platform technologies and a team of industry veterans, Viance aims to solve the manufacturing bottlenecks that often delay the delivery of life-changing treatments to patients. Their business model centers on high-touch partnerships with biotech developers to optimize production scalability and regulatory compliance.